LOW Q1 2026 Earnings EPS Tops Estimates Amid Modest Revenue Headwinds CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase HPK Q1 2026 Earnings Significant Earnings Miss Sends Stock Lower QUCY Q4 2023 Earnings Narrowing Losses as Mainz Biomed Advances Colorectal Cancer Screening Pipeline WLDN Q1 2026 Earnings EPS Beat of 749 Surprise Drives Slight Stock Uptick CMTL Q1 2026 Earnings EPS Beats Estimates by Over 40 Despite Net Loss